Chindex International Inc. (CHDX, Financial) filed Annual Report for the period ended 2011-12-31.
Chindex Intl has a market cap of $133.2 million; its shares were traded at around $9.1 with a P/E ratio of 28.4 and P/S ratio of 2.7.
Our healthcare services revenue for the year ended December 31, 2011 was $114,397,000, an increase of approximately $40 million compared to the revenue of $74,224,000 in nine months ended December 31, 2010. The increase in net revenue is due to approximately $21 million attributable to the comparison with a nine-month short period and due to approximately $19 million attributable to growth in both inpatient and outpatient services, primarily generated by our existing facilities.
Our healthcare services revenue for the nine months ended December 31, 2010 was $74,224,000, which is a lower amount than the $85,778,000 recognized in the full fiscal year ended March 31, 2010. However, the decrease is primarily attributable to the comparison of a short nine-month period to a full 12-month fiscal year period. If the March 31, 2010 fiscal year revenue of $85.8 million is reduced by 25 percent to reflect an approximation to a 9-month period, the revenue would be $64,334,000. Then, comparing similar nine-month periods, the December 2010 9-month revenue would be approximately 15% higher than the March 31, 2010 revenue. The increase in revenue was attributable to growth in patient services in the Beijing, Shanghai and Guangzhou markets.
Salaries, wages and benefits (SWB) for the nine months ended December 31, 2010 was $40,051,000, a decrease of approximately $9 million compared to the SWB of $49,012,000 in the year ended March 31, 2010. The decrease in SWB is due to approximately $12 million attributable to the comparison with a nine-month short period and due to approximately $3.4 million attributable to growth in SWB of approximately 9 percent, due to increased headcount and increases in compensation. As a percentage of net revenue, SWB in the nine months ended December 31, 2010 was 54%, an improvement compared to 57% of net revenue for SWB expense in the year ended March 31, 2010.
Other operating expenses decreased by $321,000 or 3%. However, if the December 31, 2010 period is compared to 75% of the March 31, 2010 full fiscal year, the increase in the comparable nine-month periods is approximately 30%. The increase is primarily due to relatively low operating expenses in the prior March 31, 2010 period, due to business tax refunds received of approximately $1,000,000 attributable due to a change in China regulations that applied to for-profit healthcare entities.
Read the The complete Report
Chindex Intl has a market cap of $133.2 million; its shares were traded at around $9.1 with a P/E ratio of 28.4 and P/S ratio of 2.7.
Highlight of Business Operations:
Salaries, wages and benefits (SWB) increased 22% in the current period compared to the prior year period primarily due to the increase in average headcount up 20% from 1,016 in 2010 to 1,220 in 2011 associated with the revenue increases and development activities in our existing facilities as well as for pre-opening activities and the opening of our expanded Beijing and Tianjin facilities.Our healthcare services revenue for the year ended December 31, 2011 was $114,397,000, an increase of approximately $40 million compared to the revenue of $74,224,000 in nine months ended December 31, 2010. The increase in net revenue is due to approximately $21 million attributable to the comparison with a nine-month short period and due to approximately $19 million attributable to growth in both inpatient and outpatient services, primarily generated by our existing facilities.
Our healthcare services revenue for the nine months ended December 31, 2010 was $74,224,000, which is a lower amount than the $85,778,000 recognized in the full fiscal year ended March 31, 2010. However, the decrease is primarily attributable to the comparison of a short nine-month period to a full 12-month fiscal year period. If the March 31, 2010 fiscal year revenue of $85.8 million is reduced by 25 percent to reflect an approximation to a 9-month period, the revenue would be $64,334,000. Then, comparing similar nine-month periods, the December 2010 9-month revenue would be approximately 15% higher than the March 31, 2010 revenue. The increase in revenue was attributable to growth in patient services in the Beijing, Shanghai and Guangzhou markets.
Salaries, wages and benefits (SWB) for the nine months ended December 31, 2010 was $40,051,000, a decrease of approximately $9 million compared to the SWB of $49,012,000 in the year ended March 31, 2010. The decrease in SWB is due to approximately $12 million attributable to the comparison with a nine-month short period and due to approximately $3.4 million attributable to growth in SWB of approximately 9 percent, due to increased headcount and increases in compensation. As a percentage of net revenue, SWB in the nine months ended December 31, 2010 was 54%, an improvement compared to 57% of net revenue for SWB expense in the year ended March 31, 2010.
Other operating expenses decreased by $321,000 or 3%. However, if the December 31, 2010 period is compared to 75% of the March 31, 2010 full fiscal year, the increase in the comparable nine-month periods is approximately 30%. The increase is primarily due to relatively low operating expenses in the prior March 31, 2010 period, due to business tax refunds received of approximately $1,000,000 attributable due to a change in China regulations that applied to for-profit healthcare entities.
Read the The complete Report
